Manning, Henry Charles
Clinical Research Program Manager, School of Medicine,Johns Hopkins University, Baltimore, MD
16 Aug 2017 |
Posted by Julia Faith Houston
Regulatory Challenges and Opportunities for Digital Pathology
29 Nov 2016 | | Contributor(s):: Nick Anderson
FDA has cleared or approved a number of digital pathology devices for different intended uses, such as digital read and image analysis of immunohistochemically stained tissue slides, classification and enumeration of peripheral blood cells, and initial screening of cervical cytology slides. ...
Clinical Trials Educational Materials for Hispanics
16 Aug 2016 | | Contributor(s):: Maria L. Rangel, Natalia I. Heredia, Maria E. Fernandez
These materials include a presentation, both in Spanish and English, and a flyer, again in both Spanish and English, intended to educate Hispanic individuals on clinical trials and participation in clinical trials. They can be delivered by a community health worker, researcher, or provider....
Biospecimen and Clinical Trials Educational Videos in Asian Languages
24 Nov 2015 | | Contributor(s):: Julie Dang
Culturally appropriate, ethnic specific, community tested biospecimen and clinical trials educational videos in multiple Asian American languages (Chinese, English, Hmong, Ilokano, Korean, Tagalog, and Vietnamese).
Asian American Clinical Trials Educational Brochures (Chinese, English, Hmong, Korean, Tagalog, Vietnamese)
20 Nov 2015 | | Contributor(s):: Julie Dang
Culturally appropriate, ethnic specific, community tested clinical trials educational brochures in multiple Asian languages (Chinese, English, Hmong, Korean, Tagalog, Vietnamese). Please contact me for hard copies.
The Good,The Bad and The Ugly for Clinical Markers: Possibilities For the Future
30 Jun 2015 | | Contributor(s):: Kim Jessup
Markers are becoming more important in NCI-supported clinical trials. These trials are becoming increasingly oriented toward precision medicine. This presentation provides an overview of a database for markers used in NCI Trials as well as definitions of markers and their uses in trials....